The Pain Treatment segment focuses on developing and commercializing non-surgical joint pain injection therapies and peripheral nerve stimulation products. Research and development activities include the continuous improvement of existing products and the exploration of new technologies to enhance pain relief and patient outcomes. Technologies used include advanced injection techniques and electrical stimulation. This segment addresses the therapeutic area of chronic and acute pain, impacting patients suffering from osteoarthritis, nerve damage, and other conditions. Market positioning is strong due to the minimally invasive nature of the treatments and the focus on improving quality of life. Future opportunities include expansion into new pain management applications and the development of innovative drug delivery systems. Regulatory and clinical aspects involve obtaining FDA clearances and conducting clinical trials to demonstrate safety and efficacy. Partnerships with healthcare providers and pain management specialists are crucial for market access and patient care.

The Surgical Solutions segment provides bone graft substitutes and ultrasonic medical devices for orthopedic and neurosurgical procedures. Research and development efforts are focused on improving bone fusion rates, enhancing surgical outcomes, and developing advanced surgical tools. Technologies include bone graft substitutes, ultrasonic devices for bone sculpting, and tissue debridement. This segment addresses the therapeutic areas of bone fractures, spinal fusion, and tumor removal, impacting patients requiring surgical interventions. Market positioning is based on providing innovative solutions that improve surgical precision and patient recovery. Future opportunities include the development of new bone graft materials and the expansion of ultrasonic device applications. Regulatory and clinical aspects involve obtaining FDA approvals for new devices and conducting clinical trials to demonstrate safety and efficacy. Partnerships with orthopedic surgeons and neurosurgeons are essential for product adoption and market penetration.

The Restorative Therapies segment focuses on providing solutions for fracture care, chronic wound healing, and advanced rehabilitation. Research and development activities include the development of ultrasonic bone healing systems, skin allografts, and rehabilitation devices. Technologies used include ultrasound, advanced wound care materials, and rehabilitation robotics. This segment addresses the therapeutic areas of fracture healing, chronic wounds, and post-operative rehabilitation, impacting patients with fractures, skin ulcers, and mobility impairments. Market positioning is based on providing innovative solutions that accelerate healing and improve patient function. Future opportunities include the development of new wound care products and the expansion of rehabilitation device capabilities. Regulatory and clinical aspects involve obtaining FDA clearances and conducting clinical trials to demonstrate safety and efficacy. Partnerships with physicians, hospitals, and rehabilitation centers are crucial for market access and patient care.